Role of adrenergic receptors in human coronary vasomotion

Heart

Volumn 95, Issue 7, 2009, Pages 603-608

  Barbato, Emanuele ^a,b  

^a Cardiovascular Center OLV Aalst   (Belgium)

^b NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR;

ADRENERGIC ACTIVITY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY BLOOD VESSEL; GENETIC POLYMORPHISM; HEART MUSCLE BLOOD FLOW; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; VASOMOTOR REFLEX;

CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE;

EID: 64749095666     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.150888     Document Type: Review

References (20)

1. Heusch G, Baumgart D, Camici P, et al. α-adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 2000;101:689-94.
2. Hodgson JM, Cohen MD, Szentpetery S, et al. Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 1989;79:797-809.
3. 2-receptormediated dilation of isolated human coronary arterioles. Circulation 2002;106:550-5.
4. 3-adrenoceptors mediate vasorelaxation of human coronary. Circulation 2004;110:948-54.
5. Miyashiro JK, Feigl EO. Feedforward control of coronary blood flow via coronary β-receptor stimulation. Circ Res 1993;73:252- 63.
6. Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 2006;100:323-37.
7. Indolfi C, Piscione F, Villari B, et al. Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 1992;86:1116-24.
8. Baumgart D, Haude M, Goerge G, et al. Augmented a-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 1999;99:2090-7.
9. Barbato E, Bartunek J, Wyffels E, et al. Effects of intravenous dobutamine on coronary vasomotion in humans. J Am Coll Cardiol 2003;42:1596-601.
10. 2-adrenergic receptors in human atherosclerotic coronary arteries. Circulation 2005;111:288-94.
11. Togni M, Vigorito F, Windecker S, et al. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther 2007;21:99-108.
12. Julius BK, Vassalli G, Mandinov L, et al. α-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries. J Am Coll Cardiol 1999;33:1499-505.
13. Gregorini L, Fajadet J, Robert G, et al. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents. Circulation 1994;90:895-907.
14. Harrison DG, Chilian WM, Marcus ML. Absence of functioning α- adrenergic receptors in mature canine coronary collaterals. Circ Res 1986;59:133-42.
15. Feldman RD, Christy JP, Paul ST, et al. Beta-adrenergic receptors on canine coronary collateral vessels: characterization and function. Am J Physiol 1989;257(5 Pt 2):H1634-9.
16. 2-adrenergic receptor overexpression. A novel role for the endothelial adrenergic system. Circ Res 2005;97:1182-9.
17. 2-adrenoceptor expression and dilation in coronary arterioles. Circulation 2004;110;2708-12
18. Baumgart D, Ehring T, Kowallik P, et al. Impact of alphaadrenergic coronary vasoconstriction on the transmural myocardial blood flow distribution during humoral and neuronal adrenergic activation. Circ Res 1993;73:869-86.
19. 2- adrenoceptor activation. Circ Res 1999;85:965-9.
20. Dishy V, Sofowora GG, Xie HG, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-5.